The top money raisers in biotech
The Top Line
00:00
Biotech Company's Fundraising Journey and Post-IPO Challenges
Explore the fundraising success of Metagenome, a gene editing company, through a $275 million series B round and an IPO, examining their market support test case status and decision-making post-public listing. Compare their diverse pipeline and business development challenges to established companies, discussing the impact of massive layoffs in the biotech industry.
Transcript
Play full episode
